My regularly scheduled column in Contract Pharma can be read on-line here.

This month, a discussion on the definition of cold, how it varies among industries and the possible risks and implications this has for temperature-sensitive healhcare freight in distribution.

Schenker/BAX Global, the global transportation and logistics provider, is hosting a symposium on new strategies for maintaining the integrity of biopharmaceutical cold-chain shipments on June 19, 2008 in suburban Detroit, MI.

The one day event includes three round table discussions moderated by Nick Basta, Editor, Pharmaceutical Commerce Magazine. I have been invited to participate on the panel to discuss the challenges of moving temperature-controlled heavy freight internationally. The panel also includes: Doug Britton (Director, TSA Cargo), Pete Chevoit (VP Corporate Security, Schenker/BAX), Henry Ames (Director of Marketing & Business Development, Sensitech), Maurice Barakat (President & CEO, TCP Reliable), Curt Cole (CEO, Total Quality Inc.), and Malcolm Heath (Exec. VP Airfreight Operations, Schenker).

The discussion will center around large scale cargo perspectives, and will include a pre-arranged trip to the Shenker/BAX hub to observe their 747 F operation. The end goal is to link in a controlled room temperature environment USA and Europe via scheduled 747 F service, using best in class providers in data collection, measurement, packaging, ground services.

To obtain an invitation to this event, contact Bob Gahan at BAX Global. His contact information, along with more specific details (including a unique dinner guest speaker) are attached.

(Click in the attached file below).